ERBB2 and in situ carcinoma: Moreover, the pathological features of increased malignancy, such as tumor invasion, were associated with HER2, demonstrated by significant EGFR and HER2 mRNA expression in invasive matrix-producing carcinoma compared to in situ carcinoma [48].